Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

被引：0
|
作者：
Falcone, Umberto [1 ,2 ]
Jiang, Haiyan [3 ]
Bashir, Shaheena [3 ]
Tsang, Richard [4 ]
Kukreti, Vishal [1 ,2 ]
Keating, Armand [1 ,2 ]
Crump, Michael [1 ,2 ]
Kuruvilla, John [1 ,2 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PLUS RITUXIMAB; FREE SURVIVAL; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; SUPERIOR; THERAPY; CHOP;
D O I：
10.1038/s41409-017-0054-8
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [31] Late Effects after Treatment in Mantle Cell Lymphoma: No Difference By Intensity of First-Line Regimens with or without Autologous Stem Cell Transplantation
    Ekberg, Sara
    Smedby, Karin E.
    Albertsson-Lindblad, Alexandra
    Jerkeman, Mats
    Weibull, Caroline
    Glimelius, Ingrid
    BLOOD, 2021, 138
  • [32] Rituximab maintenance therapy post autologous stem cell transplant (ASCT)
    Rice, R. D.
    Moskowitz, C. H.
    EJC SUPPLEMENTS, 2005, 3 (02): : 284 - 284
  • [33] Maintenance rituximab in mantle-cell lymphoma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2017, 18 (11): : E647 - E647
  • [34] AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN FIRST REMISSION FOR PATIENTS WITH MANTLE CELL LYMPHOMA IS ASSOCIATED WITH PROLONGED SURVIVAL
    Siddiqui, M. A.
    Johnston, P. B.
    Inwards, D. J.
    Ansell, S. M.
    Porrata, L. F.
    Micallef, I. N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 35 - 35
  • [35] RITUXIMAB MAINTENANCE THERAPY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION PROLONGS PROGRESSION FREE SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA
    Dietrich, S.
    Weidle, J.
    Meissner, J.
    Radujkovic, A.
    Ho, A.
    Dreger, P.
    Witzens-Harig, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S180 - S181
  • [36] Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation Prolongs Progression Free Survival In Patients With Mantle Cell Lymphoma
    Dietrich, Sascha
    Weidle, Julia
    Meissner, Julia
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Witzens-Harig, Mathias
    BLOOD, 2013, 122 (21)
  • [37] Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma
    Staton, Ashley D.
    Langston, Amelia A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S96 - S99
  • [38] Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
    Gile, Jennifer Jane
    Bock, Allison M.
    Tawfiq, Reema K.
    Larson, Melissa C.
    Poonsombudlert, Kittika
    Maliske, Seth M.
    Maurer, Matthew J.
    Cerhan, James R.
    Kabat, Brian
    Gysbers, Brianna
    Smith, Katherine
    Hwang, Steven R.
    Inwards, David J.
    Paludo, Jonas
    Ansell, Stephen M.
    Habermann, Thomas M.
    Ayyappan, Sabarish
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Wang, Yucai
    BLOOD, 2022, 140 : 6517 - 6519
  • [39] Long-Term Results of Cytarabine-Containing Induction Followed By Consolidation with Autologous Stem Cell Transplant and Rituximab Maintenance As Primary Treatment for Mantle Cell Lymphoma
    Falcone, Umberto
    Bashir, Shaheena
    Al-Farsi, Khalil
    Watkins, Laurie
    Turvey, C. Denise
    Franke, Norman
    Keating, Armand
    Crump, Michael
    Kuruvilla, John
    BLOOD, 2015, 126 (23)
  • [40] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma
    S Dietrich
    J Weidle
    M Rieger
    J Meissner
    A Radujkovic
    A D Ho
    P Dreger
    M Witzens-Harig
    Leukemia, 2014, 28 : 708 - 709
12345